Comparative Analysis of Subcuticular Suture Materials in Cesarean Section

NCT06543329 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-08-09

No results posted yet for this study

Summary

1.1. Background and Rationale Cesarean section is one of the most common surgical procedures performed worldwide. The choice of suture material for closing the skin incision is crucial, as it can influence wound healing, the risk of wound complications, and the cosmetic outcome. Subcuticular suturing, a technique where the suture is placed just under the skin, is favored for its aesthetic benefits and reduced risk of infection. However, the type of suture material used can significantly impact these outcomes. This study aims to provide a comparative analysis of various subcuticular suture materials used in cesarean sections, focusing on wound complications and incision outcomes.

1.2. Objective of the Study The objective of this study is to compare the incidence of wound complications and the quality of incision outcomes associated with different subcuticular suture materials used in cesarean sections. By doing so, the investigators aim to identify the most effective suture material for minimizing wound complications and optimizing cosmetic results.

Conditions

  • Cesarean Wound Disruption With Postnatal Complication

Interventions

PROCEDURE

polyglactin 910

75 PARTICIPANT, Vicryl suture was used in subcuticular suture

PROCEDURE

poliglecaprone 25

75 PARTICIPANT, monocryl suture was used in subcuticular suture

PROCEDURE

polypropylene

75 PARTICIPANT, Prolene suture was used in subcuticular suture

PROCEDURE

polyester

75 PARTICIPANT, Polyester suture was used in subcuticular suture

Sponsors & Collaborators

  • Kafrelsheikh University

    collaborator OTHER
  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed N Afifi, MD · Kafrelsheikh University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-07-31
Completion
2025-08-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06543329 on ClinicalTrials.gov